home / stock / nvcr / nvcr news


NVCR News and Press, NovoCure Limited From 05/23/19

Stock Information

Company Name: NovoCure Limited
Stock Symbol: NVCR
Market: NASDAQ
Website: novocure.com

Menu

NVCR NVCR Quote NVCR Short NVCR News NVCR Articles NVCR Message Board
Get NVCR Alerts

News, Short Squeeze, Breakout and More Instantly...

NVCR - FDA OKs Novocure's TTF for mesothelioma under HDE status; shares up 4% after hours

The FDA approves  Novocure's (NASDAQ: NVCR ) NovoTTF-100L System, combined with Eli Lilly's (NYSE: LLY ) Alimta (pemetrexed) and platinum-based chemo, for the first-line treatment of locally advanced or metastatic malignant pleural mesothelioma (MPM). More news on: NovoCure Limited, ...

NVCR - Bulletproof Investing Performance Update: Week 78

Safety First: NASCAR driver Johanna Long and her helmet (Image Credit: Gearheads ) Bulletproof Investing: Week 78 Performance Each week since the beginning of June 2017, I have presented at least two hedged portfolios created by Portfolio Armor to my Bulletproof Investing subscribers. T...

NVCR - Daily Insider Ratings Round Up 5/9/19

InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signifi...

NVCR - Medicare Issues Proposed Local Coverage Determination that Provides Coverage of Optune® for Newly Diagnosed Glioblastoma

Novocure (NASDAQ: NVCR) today announced the Medicare durable medical equipment (DME) Medicare Administrative Contractors (MACs) have issued a proposed local coverage determination (LCD ) that provides coverage of Tumor Treating Fields, or Optune, for newly diagnosed glioblastoma (GBM). Pr...

NVCR - Novocure Limited (NVCR) CEO Asaf Danziger on Q1 2019 Results - Earnings Call Transcript

Start Time: 08:00 End Time: 08:40 Novocure Limited (NVCR) Q1 2019 Earnings Conference Call May 02, 2019, 08:00 AM ET Company Participants Bill Doyle - Executive Chairman Asaf Danziger - CEO Wilco Groenhuysen - CFO Ely Benaim - CMO Ashley Cordova - SVP, Finance and IR C...

NVCR - NovoCure Q1 top line up 41%

NovoCure ( NVCR )  Q1 results : Revenues: $73.3M (+40.7%). More news on: NovoCure Limited, Healthcare stocks news, Earnings news and commentary, Read more ...

NVCR - NovoCure Limited 2019 Q1 - Results - Earnings Call Slides

The following slide deck was published by NovoCure Limited in conjunction with their 2019 Q1 earnings Read more ...

NVCR - NovoCure beats by $0.02, beats on revenue

NovoCure (NASDAQ: NVCR ): Q1 GAAP EPS of -$0.13 beats by $0.02 . More news on: NovoCure Limited, Earnings news and commentary, Healthcare stocks news, Read more ...

NVCR - Novocure Reports First Quarter 2019 Financial Results and Provides Company Update

Quarterly net revenues of $73.3 million, representing 41 percent growth versus the first quarter 2018 and 5 percent growth versus the fourth quarter 2018 Mesothelioma humanitarian device exemption application under FDA review Enrollment ongoing in four phase 3 pivotal trials, crea...

NVCR - Novocure Announces the International Journal of Radiation Oncology, Biology, Physics Publishes Data Demonstrating Higher Doses of Tumor Treating Fields Improved Survival of Newly Diagnosed Glioblastoma Patients

The study provides a definition for Tumor Treating Fields dose and sets a framework for future work on Tumor Treating Fields dosimetry and treatment planning The International Journal of Radiation Oncology, Biology, Physics, known in the field as the Red Journal, is the official journa...

Previous 10 Next 10